San Francisco; Portland
Peter Lamb, a partner working across our Bay Area and Pacific Northwest offices, is a member of the Corporate Group. Peter advises private equity sponsors, technology investors, and well established private and public technology and life sciences companies.
Peter advises private equity funds and their portfolio companies on M&A and minority and majority investments. He also advises a range of mid- to late-stage private technology companies, including Aptean, Duetto Research, Modernizing Medicine, ProCare, Qualifacts, Sagent Lending Solutions, SOC Telemed, Stripe and Zimperium. Peter regularly works with Warburg Pincus on a wide range of technology, healthcare IT and life sciences platform investments and portfolio company transactions.
Peter has also advised on the IPOs and follow-ons of numerous companies, including Cortexyme, Twist Bioscience, Elevate Financial, AVG Technologies, Pandora Media, Chegg, Portola Pharmaceuticals and ZS Pharma. His experience includes a wide range of public and private company M&A, growth equity and public market financings for tech, life sciences and private equity clients, as well as numerous cross-border buy- and sell-side M&A representations, including the $1.3 billion sale of AVG Technologies to Avast Software, and a dozen roll-up acquisitions for TA Associates and Vista Equity-backed Aptean.